home / stock / eprxf / eprxf quote
Last: | $3.04 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $3.04 |
High: | $0 |
Low: | $0 |
Volume: | 10 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.04 | $0 | $3.04 | $0 | $0 | 10 | 04-03-2024 |
$3.04 | $3.24 | $3.04 | $3.24 | $3.04 | 800 | 04-02-2024 |
$3.24 | $3.15 | $3.24 | $3.24 | $3.15 | 31,545 | 03-29-2024 |
$3.24 | $3.15 | $3.24 | $3.24 | $3.15 | 31,545 | 03-28-2024 |
$3.17 | $3.23 | $3.17 | $3.23 | $3.17 | 3,600 | 03-25-2024 |
$3.23 | $3.2 | $3.23 | $3.23 | $3.18 | 5,385 | 03-15-2024 |
$3.05 | $0 | $3.05 | $0 | $0 | 10 | 03-14-2024 |
$3.05 | $3 | $3.05 | $3.05 | $3 | 2,100 | 03-13-2024 |
$2.9341 | $2.9595 | $2.9341 | $2.9597 | $2.9341 | 8,785 | 03-12-2024 |
$4.62 | $4.62 | $4.62 | $4.62 | $4.62 | 500 | 03-11-2024 |
$5.01 | $5.15 | $5.01 | $5.15 | $5.01 | 6,000 | 02-29-2024 |
$5.2 | $5.2177 | $5.2 | $5.2177 | $5.2 | 2,940 | 02-21-2024 |
$5.3 | $5.33 | $5.3 | $5.33 | $5.3 | 19,200 | 02-20-2024 |
$5.37 | $5.58 | $5.37 | $5.58 | $5.37 | 10,200 | 02-19-2024 |
$5.37 | $5.58 | $5.37 | $5.58 | $5.37 | 10,200 | 02-16-2024 |
$5.16 | $5.16 | $5.16 | $5.16 | $5.16 | 200 | 02-14-2024 |
$5.4794 | $5.46 | $5.4794 | $5.4794 | $5.46 | 2,740 | 02-09-2024 |
$5.2503 | $5.2503 | $5.2503 | $5.2503 | $5.2503 | 300 | 02-08-2024 |
$4.32 | $4.36 | $4.32 | $4.4074 | $4.32 | 4,000 | 02-05-2024 |
$4.5 | $4.4299 | $4.5 | $4.5 | $4.4299 | 2,500 | 02-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
Eupraxia Pharmaceuticals Company Name:
EPRXF Stock Symbol:
OTCMKTS Market:
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 15, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company, today announced that it has closed i...
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company, today announced that it has priced i...
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company, today announced the launch of an ove...